Compare Illumina, Inc. (ILMN) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Tempus AI — how do they compare? Illumina, Inc. trades at $193.06 (market cap $29.12B), while Tempus AI trades at $55.63 (market cap $10.05B). The key difference: Illumina, Inc. is far larger — about 2.9× Tempus AI's market cap, and Illumina, Inc. is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.
| ILMN | TEM | |
|---|---|---|
Market Cap | $29.12B | $10.05B |
Sector | Health | Broad Market / Factor |
52-Week High | $205.10 | $103.25 |
52-Week Low | $91.00 | $41.55 |
Enterprise Value | $30.48B | $10.68B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
